This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Crore Revenue by FY26, Promoter and FIIs Increased their Stake This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Crore Revenue by FY26, Promoter and FIIs Increased their Stake The company has given returns of 46.23 per cent in a year. Prajwal Wakhare / Thursday, August 8, 2024 / Article rating: 3.8